| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | 10.18% | JP Morgan | $20.5 → $21 | Maintains | Overweight |
| 07/26/2023 | 10.18% | Citigroup | $20 → $21 | Maintains | Buy |
| 07/26/2023 | 10.18% | RBC Capital | $20 → $21 | Maintains | Outperformer |
| 07/26/2023 | 3.62% | Wells Fargo | $19.5 → $19.75 | Maintains | Equal-Weight |
| 07/26/2023 | 4.93% | JMP Securities | → $20 | Reiterates | Market Outperform → Market Outperform |
| 06/16/2023 | 7.56% | B. Riley Securities | → $20.5 | Initiates Coverage On | → Buy |
| 04/28/2023 | 4.93% | Citigroup | $22 → $20 | Maintains | Buy |
| 04/27/2023 | 4.93% | JMP Securities | $23 → $20 | Maintains | Outperform |
| 04/26/2023 | 4.93% | RBC Capital | $21 → $20 | Maintains | Outperform |
| 04/18/2023 | -5.56% | Wells Fargo | → $18 | Downgrades | Overweight → Equal-Weight |
| 03/13/2023 | 20.67% | JMP Securities | → $23 | Reiterates | → Market Outperform |
| 02/08/2023 | 15.42% | Citigroup | $21 → $22 | Maintains | Buy |
| 02/08/2023 | 7.56% | JP Morgan | $21 → $20.5 | Maintains | Overweight |
| 10/27/2022 | 10.18% | Citigroup | $24 → $21 | Maintains | Buy |
| 10/26/2022 | 7.56% | Raymond James | $21 → $20.5 | Maintains | Outperform |
| 10/26/2022 | 4.93% | Wells Fargo | $19 → $20 | Maintains | Overweight |
| 10/24/2022 | -0.31% | Wells Fargo | $20 → $19 | Maintains | Overweight |
| 07/28/2022 | 15.42% | JMP Securities | $24 → $22 | Maintains | Market Outperform |
| 07/27/2022 | 10.18% | Raymond James | $23 → $21 | Maintains | Outperform |
| 04/27/2022 | 12.8% | Wells Fargo | $23 → $21.5 | Maintains | Overweight |
| 04/27/2022 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 04/25/2022 | 20.67% | Wells Fargo | $22.5 → $23 | Maintains | Overweight |
| 02/10/2022 | 20.67% | Raymond James | $22 → $23 | Maintains | Outperform |
| 12/03/2021 | 15.42% | Janney Montgomery Scott | → $22 | Initiates Coverage On | → Buy |
| 10/27/2021 | 15.42% | Raymond James | $21 → $22 | Maintains | Outperform |
| 10/25/2021 | 19.36% | Wells Fargo | $22 → $22.75 | Maintains | Overweight |
| 08/02/2021 | 10.18% | Raymond James | $20 → $21 | Maintains | Outperform |
| 07/30/2021 | 15.42% | RBC Capital | $21 → $22 | Maintains | Outperform |
| 04/29/2021 | 10.18% | Wedbush | $20 → $21 | Maintains | Outperform |
| 04/29/2021 | 4.93% | Raymond James | $19 → $20 | Maintains | Outperform |
| 02/11/2021 | -0.31% | Raymond James | $17.5 → $19 | Maintains | Outperform |
| 01/08/2021 | -8.18% | Raymond James | $16 → $17.5 | Maintains | Outperform |
| 12/10/2020 | -10.81% | Barclays | → $17 | Downgrades | Overweight → Equal-Weight |
| 10/27/2020 | — | Janney Montgomery Scott | Upgrades | Neutral → Buy | |
| 08/05/2020 | -16.05% | Raymond James | $15.5 → $16 | Maintains | Outperform |
| 06/24/2020 | -18.68% | Raymond James | $14 → $15.5 | Maintains | Outperform |
| 06/17/2020 | -18.68% | JMP Securities | $15 → $15.5 | Maintains | Market Outperform |
| 05/04/2020 | -18.68% | JP Morgan | $19.5 → $15.5 | Maintains | Overweight |
| 04/16/2020 | — | Raymond James | Upgrades | Market Perform → Outperform | |
| 04/13/2020 | -16.05% | Oppenheimer | $19 → $16 | Maintains | Outperform |
| 04/13/2020 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 04/07/2020 | -31.79% | Citigroup | $20 → $13 | Maintains | Buy |
| 04/02/2020 | — | Compass Point | Upgrades | Neutral → Buy | |
| 03/25/2020 | -21.3% | Wells Fargo | $20.5 → $15 | Maintains | Overweight |
| 11/12/2019 | 4.93% | RBC Capital | → $20 | Initiates Coverage On | → Outperform |
| 10/22/2019 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 08/23/2019 | — | Compass Point | Downgrades | Buy → Neutral | |
| 08/19/2019 | 4.93% | BMO Capital | $19 → $20 | Upgrades | Market Perform → Outperform |
| 07/31/2019 | 2.31% | Raymond James | $19 → $19.5 | Maintains | Outperform |
| 02/13/2019 | 2.31% | JMP Securities | $19 → $19.5 | Maintains | Market Outperform |
What is the target price for Ares Capital (ARCC)?
The latest price target for Ares Capital (NASDAQ: ARCC) was reported by JP Morgan on October 25, 2023. The analyst firm set a price target for $21.00 expecting ARCC to rise to within 12 months (a possible 10.18% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ares Capital (ARCC)?
The latest analyst rating for Ares Capital (NASDAQ: ARCC) was provided by JP Morgan, and Ares Capital maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Ares Capital (ARCC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ares Capital, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ares Capital was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
Is the Analyst Rating Ares Capital (ARCC) correct?
While ratings are subjective and will change, the latest Ares Capital (ARCC) rating was a maintained with a price target of $20.50 to $21.00. The current price Ares Capital (ARCC) is trading at is $19.06, which is out of the analyst's predicted range.